Sign In
test

Olga Maltseva

Catalio Capital Management, Lp

Assets Managed
$478.704M
Holdings
41
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-15.39%(2Q avg: -5.39%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Catalio Capital Management, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Catalio Capital Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 478.704M in assets, with a quarterly growth rate of -15.39% and a 2-quarter average growth rate of -5.39%. The portfolio is managed by Olga Maltseva, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
DNTH
Dianthus Therapeutics Inc
Recent Activity
Decreased -14.26%
9.83%
$47.021M
560,308 shares@ $83.92 avg price
BBIO
Bridgebio Pharma Inc
Recent Activity
New Position
6.71%
$32.081M
432,014 shares@ $74.27 avg price
ASND
Ascendis Pharma A S - Adr
Recent Activity
Increased 8.26%
6.17%
$29.532M
129,111 shares@ $228.73 avg price
BMY
Bristol-myers Squibb Co
Recent Activity
Decreased -35.06%
5.34%
$25.517M
420,727 shares@ $60.66 avg price
SNDX
Syndax Pharmaceuticals Inc
Recent Activity
Decreased -12.79%
5.1%
$24.38M
1.044M shares@ $23.36 avg price
GILD
Gilead Sciences Inc
Recent Activity
Decreased -43.34%
4.78%
$22.843M
163,905 shares@ $139.38 avg price
TERN
Terns Pharmaceuticals Inc
Recent Activity
Increased 198.66%
4.51%
$21.564M
409,031 shares@ $52.72 avg price
DFTX
Definium Therapeutics Inc
Recent Activity
New Position
4.1%
$19.618M
1.038M shares@ $18.91 avg price
SLNO
Soleno Therapeutics Inc
Recent Activity
Increased 60.36%
4.05%
$19.345M
577,808 shares@ $33.49 avg price
BSX
Boston Scientific Corp
Recent Activity
Decreased -16.95%
3.93%
$18.782M
299,318 shares@ $62.76 avg price

1-10 of 41